Mcp and Fall - a phase IV clinical study of FDA data

Summary:

Fall is reported as a side effect among people who take Mcp (pectin), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Eliquis, and have Systemic lupus erythematosus.

The phase IV clinical study analyzes which people have Fall when taking Mcp. It is created by eHealthMe based on reports of 2,073 people who have side effects when taking Mcp from the FDA, and is updated regularly.

What is Mcp?

Mcp has active ingredients of pectin. eHealthMe is studying from 2,077 Mcp users. Check the latest studies of Mcp.

What is Fall?

Fall is found to be associated with 3,291 drugs and 3,758 conditions by eHealthMe. Check the latest studies of Fall.

On Feb, 14, 2026

2,073 people reported to have side effects when taking Mcp.
Among them, 32 people (1.54%) have Fall.

Among these 32 people:

How long have people been on Mcp when they have Fall? *

What is the gender of people who have Fall when taking Mcp? *

female: 82.14 %
male: 17.86 %

What is the age of people who have Fall when taking Mcp? *

What are other drugs people take besides Mcp? *

What are other side effects people have besides Fall? *

Urinary Tract Infection: 23 people, 71.88%
Leukopenia (less number of white blood cells in blood): 18 people, 56.25%
Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs): 17 people, 53.12%
Hyperlipidaemia (presence of excess lipids in the blood): 17 people, 53.12%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 17 people, 53.12%
Gastritis Haemorrhagic (inflammation of stomach with bleeding): 17 people, 53.12%
Lymphopenia (an abnormally low level of lymphocytes in the blood): 17 people, 53.12%
Erysipelas (bacterial skin infection): 17 people, 53.12%
Pancreatitis Acute (sudden inflammation of pancreas): 17 people, 53.12%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 17 people, 53.12%

What are the existing conditions these people have? *

White Blood Cell Count Decreased: 17 people, 53.12%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 17 people, 53.12%
Lymphopenia (an abnormally low level of lymphocytes in the blood): 14 people, 43.75%
Secondary Progressive Multiple Sclerosis (a stage of ms which comes after relapsing remitting ms in many cases): 4 people, 12.50%
Progressive Relapsing Multiple Sclerosis (chronic autoimmune disease of the central nervous system in which gradual destruction of myelin occurs in patches throughout the brain or spinal cord or both): 4 people, 12.50%
Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 12.50%
Nausea (feeling of having an urge to vomit): 3 people, 9.38%
Osteoporosis (bones weak and more likely to break): 2 people, 6.25%
High Blood Cholesterol: 2 people, 6.25%
High Blood Pressure: 2 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Mcp and have Fall?

- Check whether Fall is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mcp:

Mcp (2,077 reports)

Fall treatments and more:

Fall (403,513 reports)

Browse all side effects of Mcp:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Fall:

Fall (3,291 drugs)

Browse all the conditions that are associated with Fall:

Fall (3,758 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on pectin (the active ingredients of Mcp) and Mcp (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.